Empresa Rapid Therapeutic Science Laboratories, Inc. Other OTC
Acciones
RTSL
US7534311052
Farmacéuticos
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Donal Schmidt
CEO | Chief Executive Officer | 63 | 15/11/19 |
D. Watler
DFI | Director of Finance/CFO | 75 | 15/11/19 |
Sean P. Berrier
PRN | Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
D. Watler
DFI | Director of Finance/CFO | 75 | 15/11/19 |
Donal Schmidt
CEO | Chief Executive Officer | 63 | 15/11/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 20 910 251 | 15 769 465 ( 75,41 %) | 0 | 75,41 % |
Información de la empresa
Rapid Therapeutic Science Laboratories, Inc.
558 County Road Suite 472
76444, De Leon
+
Varia. 1 de ene. | Capi. | |
---|---|---|
+41,50 % | 6201,96 M | |
-22,89 % | 4101,49 M | |
+9,36 % | 3413,4 M | |
-19,39 % | 2828,5 M | |
-11,05 % | 2287,26 M | |
+45,24 % | 1933,84 M | |
+46,81 % | 1514,74 M | |
-7,51 % | 1521,76 M | |
-18,04 % | 1494,16 M |